Targeting H19, an Imprinted Long Non-Coding RNA, in Hepatic Functions and Liver Diseases
H19 is a long non-coding RNA regulated by genomic imprinting through methylation at the locus between H19 and IGF2. H19 is important in normal liver development, controlling proliferation and impacting genes involved in an important network controlling fetal development. H19 also plays a major role...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-03-01
|
Series: | Diseases |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-9721/5/1/11 |
id |
doaj-e57f66a3cd5642238efd4f6d277c80e4 |
---|---|
record_format |
Article |
spelling |
doaj-e57f66a3cd5642238efd4f6d277c80e42020-11-24T21:26:46ZengMDPI AGDiseases2079-97212017-03-01511110.3390/diseases5010011diseases5010011Targeting H19, an Imprinted Long Non-Coding RNA, in Hepatic Functions and Liver DiseasesChad Pope0Shashank Mishra1Joshua Russell2Qingqing Zhou3Xiao-Bo Zhong4Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 N Eagleville Road, Storrs, CT 06269, USADepartment of Physiology and Neurobiology, University of Connecticut, 75 N Eagleville Road, Storrs, CT 06269, USADepartment of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 N Eagleville Road, Storrs, CT 06269, USADepartment of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 N Eagleville Road, Storrs, CT 06269, USADepartment of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 N Eagleville Road, Storrs, CT 06269, USAH19 is a long non-coding RNA regulated by genomic imprinting through methylation at the locus between H19 and IGF2. H19 is important in normal liver development, controlling proliferation and impacting genes involved in an important network controlling fetal development. H19 also plays a major role in disease progression, particularly in hepatocellular carcinoma. H19 participates in the epigenetic regulation of many processes impacting diseases, such as activating the miR-200 pathway by histone acetylation to inhibit the epithelial-mesenchymal transition to suppress tumor metastasis. Furthermore, H19’s normal regulation is disturbed in diseases, such as hepatocellular carcinoma. In this disease, aberrant epigenetic maintenance results in biallelic expression of IGF2, leading to uncontrolled cellular proliferation. This review aims to further research utilizing H19 for drug discovery and the treatment of liver diseases by focusing on both the epigenetic regulation of H19 and how H19 regulates normal liver functions and diseases, particularly by epigenetic mechanisms.http://www.mdpi.com/2079-9721/5/1/11H19liver functionslong non-coding RNAliver diseasesepigenetics |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chad Pope Shashank Mishra Joshua Russell Qingqing Zhou Xiao-Bo Zhong |
spellingShingle |
Chad Pope Shashank Mishra Joshua Russell Qingqing Zhou Xiao-Bo Zhong Targeting H19, an Imprinted Long Non-Coding RNA, in Hepatic Functions and Liver Diseases Diseases H19 liver functions long non-coding RNA liver diseases epigenetics |
author_facet |
Chad Pope Shashank Mishra Joshua Russell Qingqing Zhou Xiao-Bo Zhong |
author_sort |
Chad Pope |
title |
Targeting H19, an Imprinted Long Non-Coding RNA, in Hepatic Functions and Liver Diseases |
title_short |
Targeting H19, an Imprinted Long Non-Coding RNA, in Hepatic Functions and Liver Diseases |
title_full |
Targeting H19, an Imprinted Long Non-Coding RNA, in Hepatic Functions and Liver Diseases |
title_fullStr |
Targeting H19, an Imprinted Long Non-Coding RNA, in Hepatic Functions and Liver Diseases |
title_full_unstemmed |
Targeting H19, an Imprinted Long Non-Coding RNA, in Hepatic Functions and Liver Diseases |
title_sort |
targeting h19, an imprinted long non-coding rna, in hepatic functions and liver diseases |
publisher |
MDPI AG |
series |
Diseases |
issn |
2079-9721 |
publishDate |
2017-03-01 |
description |
H19 is a long non-coding RNA regulated by genomic imprinting through methylation at the locus between H19 and IGF2. H19 is important in normal liver development, controlling proliferation and impacting genes involved in an important network controlling fetal development. H19 also plays a major role in disease progression, particularly in hepatocellular carcinoma. H19 participates in the epigenetic regulation of many processes impacting diseases, such as activating the miR-200 pathway by histone acetylation to inhibit the epithelial-mesenchymal transition to suppress tumor metastasis. Furthermore, H19’s normal regulation is disturbed in diseases, such as hepatocellular carcinoma. In this disease, aberrant epigenetic maintenance results in biallelic expression of IGF2, leading to uncontrolled cellular proliferation. This review aims to further research utilizing H19 for drug discovery and the treatment of liver diseases by focusing on both the epigenetic regulation of H19 and how H19 regulates normal liver functions and diseases, particularly by epigenetic mechanisms. |
topic |
H19 liver functions long non-coding RNA liver diseases epigenetics |
url |
http://www.mdpi.com/2079-9721/5/1/11 |
work_keys_str_mv |
AT chadpope targetingh19animprintedlongnoncodingrnainhepaticfunctionsandliverdiseases AT shashankmishra targetingh19animprintedlongnoncodingrnainhepaticfunctionsandliverdiseases AT joshuarussell targetingh19animprintedlongnoncodingrnainhepaticfunctionsandliverdiseases AT qingqingzhou targetingh19animprintedlongnoncodingrnainhepaticfunctionsandliverdiseases AT xiaobozhong targetingh19animprintedlongnoncodingrnainhepaticfunctionsandliverdiseases |
_version_ |
1725977745362518016 |